Jennison Associates’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-10,530
Closed -$1.05M 708
2019
Q3
$1.05M Sell
10,530
-92,578
-90% -$8.8M ﹤0.01% 542
2019
Q2
$9.53M Sell
103,108
-120,347
-54% -$11.4M 0.01% 436
2019
Q1
$21.1M Sell
223,455
-5,715,333
-96% -$500M 0.02% 346
2018
Q4
$381M Sell
5,938,788
-2,289,336
-28% -$169M 0.43% 50
2018
Q3
$736M Buy
8,228,124
+2,748,302
+50% +$243M 0.68% 43
2018
Q2
$435M Sell
5,479,822
-3,287,290
-37% -$273M 0.42% 48
2018
Q1
$782M Sell
8,767,112
-1,048,699
-11% -$101M 0.78% 44
2017
Q4
$1.02B Sell
9,815,811
-5,146,596
-34% -$581M 1.01% 32
2017
Q3
$2.18B Buy
14,962,407
+1,546,673
+12% +$211M 2.24% 8
2017
Q2
$1.74B Buy
13,415,734
+156,864
+1% +$19.2M 1.85% 10
2017
Q1
$1.65B Sell
13,258,870
-2,298,837
-15% -$275M 1.77% 11
2016
Q4
$1.8B Sell
15,557,707
-363,295
-2% -$40.5M 2.01% 8
2016
Q3
$1.66B Buy
15,921,002
+1,967,645
+14% +$213M 1.8% 10
2016
Q2
$1.38B Sell
13,953,357
-144,415
-1% -$14.9M 1.52% 14
2016
Q1
$1.41B Sell
14,097,772
-8,388
-0.1% -$864K 1.48% 13
2015
Q4
$1.69B Buy
14,106,160
+1,741,019
+14% +$201M 1.66% 11
2015
Q3
$1.34B Buy
12,365,141
+2,728,714
+28% +$339M 1.37% 14
2015
Q2
$1.12B Sell
9,636,427
-3,525,188
-27% -$403M 1.02% 22
2015
Q1
$1.52B Sell
13,161,615
-3,309,525
-20% -$395M 1.39% 12
2014
Q4
$1.84B Sell
16,471,140
-36,639
-0.2% -$3.86M 1.72% 6
2014
Q3
$1.56B Buy
16,507,779
+1,976,980
+14% +$178M 1.45% 8
2014
Q2
$1.25B Buy
14,530,799
+2,677,561
+23% +$204M 1.15% 19
2014
Q1
$827M Buy
11,853,238
+838,328
+8% +$66.4M 0.79% 40
2013
Q4
$931M Buy
11,014,910
+2,934,678
+36% +$232M 0.91% 32
2013
Q3
$622M Buy
8,080,232
+1,196,718
+17% +$83.9M 0.65% 47
2013
Q2
$402M Buy
+6,883,514
New +$414M 0.45% 60

Other funds holding CELG